CDX1 is an intestine-specific transcription factor with a role in directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. Cdx1 positively regulates its own expression in the small intestine and colon of fetus and adult and promotes cellular growth and differentiation in epithelial intestinal cells.
| Inventor | Institute |
|---|---|
| Walter Bodmer | University of Oxford |
| Cat. #: | 151546 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Apoptosis and autophagy;Cancer;Genetics |
| Application: | ChIP ; IF ; WB ; ChIP-seq |
| Target: | CDX1 |
| Reactivity: | Human |
| Clone: | 123a |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | Caudal Type Homeobox 1 |
|---|---|
| Product description: | CDX1 is an intestine-specific transcription factor with a role in directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. Cdx1 positively regulates its own expression in the small intestine and colon of fetus and adult and promotes cellular growth and differentiation in epithelial intestinal cells. A reduction in human Cdx1 expression is associated with colorectal tumorigenesis. Both Cdx1 and Cdx2 genes must be expressed to reduce tumorigenic potential, to increase sensitivity to apoptosis and to reduce cell migration, suggesting that the two genes control the normal phenotype by independent pathways. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 32 kDa |
| Immunogen: | Human CDX-1 N-terminal peptide |
| Myeloma used: | P3/NS1/1-Ag4.1 |
| Target background: | CDX1 is an intestine-specific transcription factor with a role in directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. Cdx1 positively regulates its own expression in the small intestine and colon of fetus and adult and promotes cellular growth and differentiation in epithelial intestinal cells. A reduction in human Cdx1 expression is associated with colorectal tumorigenesis. Both Cdx1 and Cdx2 genes must be expressed to reduce tumorigenic potential, to increase sensitivity to apoptosis and to reduce cell migration, suggesting that the two genes control the normal phenotype by independent pathways. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Jones et al. 2015. Proc Natl Acad Sci U S A. 112(13):E1550-8. PMID: 25775580. The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation. Ashley et al. 2013. Cancer Res. 73(18):5798-809. PMID: 23867471. Stem cell differentiation and lumen formation in colorectal cancer cell lines and primary tumors. Yeung et al. 2011. Proc Natl Acad Sci U S A. 108(11):4382-7. PMID: 21368208. Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Yeung et al. 2010. Proc Natl Acad Sci U S A. 107(8):3722-7. PMID: 20133591. Cancer stem cells from colorectal cancer-derived cell lines. Chan et al. 2009. Proc Natl Acad Sci U S A. 106(6):1936-41. PMID: 19188603. Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.